111 (YI) Cash from Investing Activities Growth (3y) (2020 - 2025)
111 (YI) Cash from Investing Activities Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 55.25% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -280.15% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -25.76% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -17.33% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 52.94% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 22.77% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 42.80% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 45.94% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42.80% |
| Sep 30, 2025 | -31.97% |
| Jun 30, 2025 | 84.16% |
| Mar 31, 2025 | -26.86% |
| Dec 31, 2024 | -43.75% |
| Sep 30, 2024 | 29.84% |
| Jun 30, 2024 | -62.34% |
| Mar 31, 2024 | -31.91% |
| Dec 31, 2023 | 31.12% |
| Sep 30, 2023 | 26.98% |
| Jun 30, 2023 | 264.97% |
| Mar 31, 2023 | -136.02% |
| Dec 31, 2022 | -45.62% |
| Sep 30, 2022 | -18.56% |
| Jun 30, 2022 | -44.54% |
| Mar 31, 2022 | 55.56% |
| Dec 31, 2021 | 24.74% |
| Sep 30, 2021 | -55.04% |
| Jun 30, 2021 | -39.31% |
| Mar 31, 2021 | 55.57% |